Source: SuperSonic Imagine

SuperSonic Imagine Appoints Bernard Doorenbos as Interim President and Chief Executive Officer

AIX-EN-PROVENCE, FRANCE--(Marketwired - Dec 14, 2015) -  SuperSonic Imagine (EURONEXT PARIS: SSI) (FR0010526814), the highly innovative ultrasound company, today announced the appointment of Bernard Doorenbos, previously member of the Supervisory Board, as Interim President and Chief Executive Officer to succeed to Tom Egelund.

"It is a pleasure to welcome Bernard as President and Chief Executive Officer. His main objectives will be to strengthen the commercial action in the company's key territories, increase its visibility within the investment community, and continue to develop the company through its pipeline of products and partnerships. Bernard's expertise in managing technological and industrial companies at this stage of development will be extremely helpful to the team. I am confident in his ability to implement the company's strategy," commented Hermann Requardt, Chairman of the Supervisory Board.

Mr. Bernard Doorenbos has a strong track record of successfully realizing growth and earnings in a variety of companies. He started his career as a naval officer fulfilling various functions in the Royal Netherlands Navy. Hereafter he worked until 1990 at Philips Medical Systems in Paris as a Product Manager and later as Head of Sales and Services for Latin America. From 1990 to 1997, he worked for Thomson CSF (Thales), from 1990 to 1992 in Paris and from 1992 to 1997 as Managing Director of Signaal USFA (specialized among others in infrared cameras and Stirling cooling systems). From 1997 to 2001, he worked as CEO of Axxicon Group NV (a listed company, specialized in moulds and plastic components). From 2001 to 2003 he has been the CEO of Neways Electronics International and between 2003 and 2005 CEO of Vilenzo International N.V. (both listed companies). He served as an Interim President of Supervisory Board at SuperSonic Imagine SA from May 29, 2015 to October 1, 2015 and has been its Member of Supervisory Board since May 29, 2015. He has been the Chairman and Member of the Supervisory Board of Nedstat Ltd. (now comScore) between 2001 and 2011. He has been a Member of the Board of Supervisory Directors of Nedcon Groep N.V. between 2003 and 2010. Between 2013 and 2015, he has been a member of the advisory board of Type22 (recently sold to Sita). Between 2006 and 2013, he provided leadership as CEO for various industrial companies in the Netherlands and Belgium. He obtained his Master of Science in Electronics from the Technical University of Delft and Master's Degree in Financial Economics from the University of Amsterdam (UVA).

About SuperSonic Imagine
Founded in 2005 and based in Aix-en-Provence (France), SuperSonic Imagine is a company specializing in medical imaging. The company designs, develops and markets a revolutionary ultrasound system, Aixplorer®, with an UltraFast™ platform that can acquire images 200 times faster than conventional ultrasound systems. Aixplorer is the only system that can image two types of waves: ultrasound waves ensure excellent image quality and shear waves, which allow physicians to visualize and analyze the stiffness of tissue in a real-time, reliable, reproducible and non-invasive manner. This innovation, ShearWave™ Elastography, significantly improves the detection and characterization of numerous pathologies in several applications including breast, thyroid, liver and prostate. SuperSonic Imagine has been granted regulatory clearances for the commercialization of Aixplorer in the main global markets. Over the past years, SuperSonic Imagine enjoyed the backing of several prestigious investors, among which Auriga Partners, Edmond de Rothschild Investment Partners, Bpifrance, Omnes Capital and NBGI. For more information about SuperSonic Imagine, please go to www.supersonicimagine.com

Contact Information:

Contact information:

SuperSonic Imagine
Bernard Doorenbos
President and CEO
+31 6 53 90 42 18

SuperSonic Imagine
Marketing & Communication
Emmanuelle Vella

+33 4 86 79 03 27

NewCap
Investor Relations - EU
Pierre Laurent / Florent Alba

+33 1 44 71 98 55

Blueprint Life Science Group
Investor Relations - US
Candice Knoll

+1 415 375 3340 Ext. 4

ComCorp
Media Relations
Adelaide Manester

+33 1 58 18 32 44